Maze Therapeutics became the latest drug developer to list in New York on Friday, with its shares rising nearly 1% in their debut, giving the company a valuation of $690.37 million. The muted market ...

Industries and taxpayers await changes in Union Budget 2025, presented by Finance Minister Nirmala Sitharaman on February 1, ...